You will learn how to build a biotech-sum-of-the-parts valuation the way it’s done on the job.
Ideal for investment banking private equity and VC professionals focusing on the biotechnology industry, you will learn how to build a biotech-sum-of-the-parts valuation the way it’s done on the job.
Want to value a clinical-stage, pre-revenue biotech? An ordinary discounted cash flow analysis wonât cut it. Instead, you need to build a long-range sum-of-the-parts valuation.
This 60-minute video short course + model template bridges the gap between academics and the real world and equips trainees with the practical modeling skill set needed to build a biotech SOTP Valuation.
This course assumes no prior knowledge in biotech company valuation.
This biotech sum-of-the-parts valuation course is designed for professionals and those pursuing a career in the following finance careers:
Biotech Sum of the Parts Valuation
This course does not assume a prior background in Biotech or Healthcare. However, those who enroll should have an introductory knowledge of accounting (e.g. interaction of balance sheet, cash flow, and income statement) and proficiency in Excel. Students with no prior background in Accounting should enroll in the Accounting Crash Course. Students with limited experience using Excel should enroll in the Excel Crash Course.
There are no reviews yet.
You must be <a href="https://wislibrary.org/my-account/">logged in</a> to post a review.